|
|
TOP NEWS
|
 08/04/2010
[Industry news]
MicuRx, Cumencor, Pfizer to discover TB drugs in China
Three companies have come together to discover therapeutic agents to treat multidrug resistant TB in China.
|
| |
|
Three companies have come together to discover therapeutic agents to treat multidrug resistant TB in China.
The companies are MicuRx Pharmaceuticals Cumencor Pharmaceuticals and Pfizer. The former companies have tied up with Pfizer. While Pfizer and MicuRx are based in the US, Cumencor is a Chinese company. A release said Cumencor will apply MicuRx\'s proprietary technology platform to discover and develop novel antibiotics for MDR-TB. MicuRx and Cumencor are both biotechnology companies. As part of the deal, Pfizer will give an upfront payment, funding for the discovery and preclinical development of novel antibiotics to treat MDR-TB, and other milestone payments. All research will be conducted at the ZhangJiang High-Tech Park in Shanghai, China. |
|
|
|
|
